Who Needs a BRCA Gene Test? New Beauty News Genetic testing for BRCA1 and BRCA2 can reveal if you have an increased risk of developing cancer, but it’s not universally recommended for everyone. Payal Shah, MD says testing should be considered for those with family history of certain cancers. Latest News Penn Medicine Research Suggests More Cancers Can Be Treated with Drugs Than Previously Believed Penn Medicine News News | March 2023 Up to 50% of cancer-signaling proteins once believed to be immune to drug treatments due to a lack of targetable protein regions may actually be treatable, according to a new study from the Perelman School of Medicine at the University of Pennsylvania. Gregory R. Bowman, PhD, a Penn professor of Biochemistry and Biophysics and Bioengineering, leads this study as the first researcher funded by the Basser Cancer Interception Institute (BCII). His grant from the BCII supports the application of his ongoing work to BRCA-related research. Increased Germline Testing Rates Promote Crucial Breast Cancer Care OncLive News | March 2023 Susan Domchek, MD, executive director of the Basser Center, highlights her presentation on germline testing and breast cancer treatment saying, “Over the past decade, we’ve learned how useful genetic information can be when deciding on a treatment plan for a patient with breast cancer at several stages of the diagnosis.” Can We Intercept Cancer? A New Frontier in Cancer Research Penn Medicine News News | February 2023 Can we stop cancer before it starts? That’s part of the goal of cancer interception, which involves “catching” cancer cells as they begin to develop into pre-cancers or very early cancers, and halt or reverse that process. A Moment for Men’s Health Inspiring Impact - University of Pennsylvania News | February 2023 The Basser Center has launched the Men & BRCA program to accelerate research and provide men with specialized BRCA-related care. Dr. Kara Maxwell, Director of the new program, says that it is “part of a three-pronged approach comprising education, clinical care, and research.” Manage Your Cancer Risk with Genetic Testing CentralJersey.com News | February 2023 Jacquelyn Powers, MS, LCGC, a genetic counselor at the Basser Center, shares information about genetic counseling and testing services available at the Penn Medicine Mariann and Robert MacDonald Cancer Risk Evaluation Program and at the Basser Center. Founded to Stop Cancer-Causing Genetic Mutations, This Philly Research and Treatment Center Is Leading a Medical Revolution Philadelphia Magazine News | January 2023 Ovarian cancer is known as the silent killer, and Christine Hussey and her mother, Betty Walter, who have both participated in genetic testing at the Basser Center, know the importance of early detection. Biologic Factors Linked to Recurrence of BRCA1/BRCA2-Mutated Breast, Ovarian Cancers HemOnc Today News | January 2023 A study conducted at Penn Medicine’s Abramson Cancer Center has revealed possible drivers of recurrence in breast and ovarian tumors with BRCA1/BRCA2 mutations. Senior study author Katherine Nathanson, MD, the Pearl Basser Professor for BRCA-Related Research and deputy director of the Abramson Cancer Center, discussed the study results and what they might reveal about the mechanisms of cancer recurrence. Ovarian Cancer Survivor: Learning about BRCA Saved My Life Penn Medicine News News | November 2022 Trudy Orthey learned she had a BRCA2 gene mutation after a family member’s cancer diagnosis. Now as a Basser Center patient, Trudy is cancer free and shares her journey with ovarian cancer. Basser Jean Bash Brings Out Celebrities for a Good Cause Bloomberg News | November 2022 Grammy Award-winning artist, songwriter, and actress Sara Bareilles performed at the Basser Center's fourth Basser Jean Bash last week in New York City. The sold-out event raised nearly $17 million to help find a cure for BRCA-related cancers. See What Your Favorite Stars Are Up To: Sara Bareilles People News | November 2022 Sara Bareilles shows off her smile while attending the 4th Annual Basser Jean Bash held at The Glasshouse in N.Y.C. on Nov. 15, 2022. Basser Center Holds Fundraiser in Manhattan to Help Cure Cancer abc7NY News | November 2022 The Basser Center held its Basser Jean Bash on November 15th in Manhattan where all attendees wore their most stylish denim. The event it was an event about your "genes" that helped to raise money to find a cure for BRCA-related cancers. Basser Center Holds Fundraiser In NYC To Help Cure Cancer MSN.com News | November 2022 The Basser Center's celebrated their 10th year anniversary with a fundraiser that helps to raise money to find a cure for BRCA-related cancers. Analysis of Matched Primary and Recurrent BRCA1/2 Mutation-Associated Tumors Identifies Recurrence-Specific Drivers Nature Communications News | November 2022 The Basser Center research team worked to address outstanding questions about cancer recurrence in BRCA1/2 mutation carriers by performing an analysis of paired primary and recurrent BRCA1/2 mutation-associated tumors. Penn Study Illuminates Why Cancers Caused by BRCA Mutations Recur Penn Medicine News News | November 2022 Our research team at the Basser Center for BRCA uncovers possible drivers of recurrent breast and ovarian cancers among women carrying high-risk genetic mutations, pointing to methods to more effectively treat disease. Research Groups Across the US Testing Vaccines to Help Prevent, Terminate Cancer ABC10 News San Diego News | October 2022 Basser executive director, Susan Domchek, MD, speaks on a vaccine that could prevent breast cancer from developing in certain patients. She says, “We’re in the midst of a trial where we’re first vaccinating BRCA1 and BRCA2 mutation carriers who have had cancer of any type. Then we will start vaccinating BRCA1 and BRCA2 mutation carriers who have never had any cancers.” For Patients with Earliest Stage of Breast Cancer, How Much Treatment is Enough? USA Today News | October 2022 Doctors are now trying to “right-size” care for patients with ductal carcinoma in situ, what’s sometimes called “stage zero” breast cancer. Susan Domchek, MD, was quoted on these treatment opportunities and risks for patients. What’s the BRCA Gene, and How Does It Affect Breast Cancer? Katie Couric Media News | October 2022 Susan Domchek, MD discusses the significance of genetics, genetic testing, the risk of developing cancer with a BRCA gene mutation and more. Groundbreaking Study to Test a Breast Cancer Vaccine Fox29 News | October 2022 Dr. Susan Domchek, executive director of the Basser Center, is interviewed with her patient, Karen, on what leading a vaccine trial to prevent breast cancer can really mean for patients and their families. Pagination First page« First Previous page‹‹ … Page2 Page3 Page4 Page5 Current page6 Page7 Page8 Page9 Page10 … Next page›› Last pageLast »
Who Needs a BRCA Gene Test? New Beauty News Genetic testing for BRCA1 and BRCA2 can reveal if you have an increased risk of developing cancer, but it’s not universally recommended for everyone. Payal Shah, MD says testing should be considered for those with family history of certain cancers.
Penn Medicine Research Suggests More Cancers Can Be Treated with Drugs Than Previously Believed Penn Medicine News News | March 2023 Up to 50% of cancer-signaling proteins once believed to be immune to drug treatments due to a lack of targetable protein regions may actually be treatable, according to a new study from the Perelman School of Medicine at the University of Pennsylvania. Gregory R. Bowman, PhD, a Penn professor of Biochemistry and Biophysics and Bioengineering, leads this study as the first researcher funded by the Basser Cancer Interception Institute (BCII). His grant from the BCII supports the application of his ongoing work to BRCA-related research.
Increased Germline Testing Rates Promote Crucial Breast Cancer Care OncLive News | March 2023 Susan Domchek, MD, executive director of the Basser Center, highlights her presentation on germline testing and breast cancer treatment saying, “Over the past decade, we’ve learned how useful genetic information can be when deciding on a treatment plan for a patient with breast cancer at several stages of the diagnosis.”
Can We Intercept Cancer? A New Frontier in Cancer Research Penn Medicine News News | February 2023 Can we stop cancer before it starts? That’s part of the goal of cancer interception, which involves “catching” cancer cells as they begin to develop into pre-cancers or very early cancers, and halt or reverse that process.
A Moment for Men’s Health Inspiring Impact - University of Pennsylvania News | February 2023 The Basser Center has launched the Men & BRCA program to accelerate research and provide men with specialized BRCA-related care. Dr. Kara Maxwell, Director of the new program, says that it is “part of a three-pronged approach comprising education, clinical care, and research.”
Manage Your Cancer Risk with Genetic Testing CentralJersey.com News | February 2023 Jacquelyn Powers, MS, LCGC, a genetic counselor at the Basser Center, shares information about genetic counseling and testing services available at the Penn Medicine Mariann and Robert MacDonald Cancer Risk Evaluation Program and at the Basser Center.
Founded to Stop Cancer-Causing Genetic Mutations, This Philly Research and Treatment Center Is Leading a Medical Revolution Philadelphia Magazine News | January 2023 Ovarian cancer is known as the silent killer, and Christine Hussey and her mother, Betty Walter, who have both participated in genetic testing at the Basser Center, know the importance of early detection.
Biologic Factors Linked to Recurrence of BRCA1/BRCA2-Mutated Breast, Ovarian Cancers HemOnc Today News | January 2023 A study conducted at Penn Medicine’s Abramson Cancer Center has revealed possible drivers of recurrence in breast and ovarian tumors with BRCA1/BRCA2 mutations. Senior study author Katherine Nathanson, MD, the Pearl Basser Professor for BRCA-Related Research and deputy director of the Abramson Cancer Center, discussed the study results and what they might reveal about the mechanisms of cancer recurrence.
Ovarian Cancer Survivor: Learning about BRCA Saved My Life Penn Medicine News News | November 2022 Trudy Orthey learned she had a BRCA2 gene mutation after a family member’s cancer diagnosis. Now as a Basser Center patient, Trudy is cancer free and shares her journey with ovarian cancer.
Basser Jean Bash Brings Out Celebrities for a Good Cause Bloomberg News | November 2022 Grammy Award-winning artist, songwriter, and actress Sara Bareilles performed at the Basser Center's fourth Basser Jean Bash last week in New York City. The sold-out event raised nearly $17 million to help find a cure for BRCA-related cancers.
See What Your Favorite Stars Are Up To: Sara Bareilles People News | November 2022 Sara Bareilles shows off her smile while attending the 4th Annual Basser Jean Bash held at The Glasshouse in N.Y.C. on Nov. 15, 2022.
Basser Center Holds Fundraiser in Manhattan to Help Cure Cancer abc7NY News | November 2022 The Basser Center held its Basser Jean Bash on November 15th in Manhattan where all attendees wore their most stylish denim. The event it was an event about your "genes" that helped to raise money to find a cure for BRCA-related cancers.
Basser Center Holds Fundraiser In NYC To Help Cure Cancer MSN.com News | November 2022 The Basser Center's celebrated their 10th year anniversary with a fundraiser that helps to raise money to find a cure for BRCA-related cancers.
Analysis of Matched Primary and Recurrent BRCA1/2 Mutation-Associated Tumors Identifies Recurrence-Specific Drivers Nature Communications News | November 2022 The Basser Center research team worked to address outstanding questions about cancer recurrence in BRCA1/2 mutation carriers by performing an analysis of paired primary and recurrent BRCA1/2 mutation-associated tumors.
Penn Study Illuminates Why Cancers Caused by BRCA Mutations Recur Penn Medicine News News | November 2022 Our research team at the Basser Center for BRCA uncovers possible drivers of recurrent breast and ovarian cancers among women carrying high-risk genetic mutations, pointing to methods to more effectively treat disease.
Research Groups Across the US Testing Vaccines to Help Prevent, Terminate Cancer ABC10 News San Diego News | October 2022 Basser executive director, Susan Domchek, MD, speaks on a vaccine that could prevent breast cancer from developing in certain patients. She says, “We’re in the midst of a trial where we’re first vaccinating BRCA1 and BRCA2 mutation carriers who have had cancer of any type. Then we will start vaccinating BRCA1 and BRCA2 mutation carriers who have never had any cancers.”
For Patients with Earliest Stage of Breast Cancer, How Much Treatment is Enough? USA Today News | October 2022 Doctors are now trying to “right-size” care for patients with ductal carcinoma in situ, what’s sometimes called “stage zero” breast cancer. Susan Domchek, MD, was quoted on these treatment opportunities and risks for patients.
What’s the BRCA Gene, and How Does It Affect Breast Cancer? Katie Couric Media News | October 2022 Susan Domchek, MD discusses the significance of genetics, genetic testing, the risk of developing cancer with a BRCA gene mutation and more.
Groundbreaking Study to Test a Breast Cancer Vaccine Fox29 News | October 2022 Dr. Susan Domchek, executive director of the Basser Center, is interviewed with her patient, Karen, on what leading a vaccine trial to prevent breast cancer can really mean for patients and their families.
